Search results
Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoNektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Call Transcript November 7, 2023 Nektar...
Is Nektar Therapeutics (NASDAQ:NKTR) In A Good Position To Deliver On Growth Plans?
Simply Wall St. via Yahoo Finance· 2 months agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
Nektar Therapeutics (NASDAQ:NKTR) is largely controlled by institutional shareholders who own 70% of...
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights Significantly high institutional ownership implies Nektar Therapeutics' stock price is...
Nektar Therapeutics (NKTR) Q2 Loss Narrows, Sales Miss
Zacks via Yahoo Finance· 9 months agoNektar Therapeutics NKTR reported a loss of 27 cents per share for the second quarter of 2023, which...
Will Nektar Therapeutics (NASDAQ:NKTR) Spend Its Cash Wisely?
Simply Wall St. via Yahoo Finance· 8 months agoJust because a business does not make any money, does not mean that the stock will go down. For...
Following a 75% decline over last year, recent gains may please Nektar Therapeutics (NASDAQ:NKTR)...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Given the large stake in the stock by institutions, Nektar Therapeutics' stock price...
Investors Don't See Light At End Of Nektar Therapeutics' (NASDAQ:NKTR) Tunnel
Simply Wall St. via Yahoo Finance· 11 months agoYou may think that with a price-to-sales (or "P/S") ratio of 1.3x Nektar Therapeutics (NASDAQ:NKTR)...
We Think Nektar Therapeutics (NASDAQ:NKTR) Needs To Drive Business Growth Carefully
Simply Wall St. via Yahoo Finance· 1 year agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
Nektar Therapeutics (NKTR) Q1 Earnings & Revenues Beat
Zacks via Yahoo Finance· 12 months agoNektar Therapeutics NKTR reported a loss (excluding non-cash goodwill and other impairment charges)...
Nektar Therapeutics (NASDAQ:NKTR shareholders incur further losses as stock declines 11% this week,...
Simply Wall St. via Yahoo Finance· 2 years agoWhile it may not be enough for some shareholders, we think it is good to see the Nektar Therapeutics...